The global pharmaceutical contract manufacturing market size was USD 119.24 Billion in 2022 and is likely to reach USD 199.75 Billion by 2031, expanding at a CAGR of 5.9% during 2023–2031. The market growth is attributed to the increasing demand for generic drugs.
